Ravkiran Khurana

Ravkiran Khurana practices at Medina Hospital in Medina, Ohio, part of The Cleveland Clinic Foundation.

Ravkiran Khurana's NPI, 1023493368, was assigned on July 28, 2015. Ravkiran Khurana holds Ohio license 35.132723.

Ravkiran Khurana's primary practice is Medina Hospital, at 1000 East Washington Street, Medina, OH 44256 in Medina County. The practice phone is (330) 725-1000.

Ravkiran Khurana's primary practice is Medina Hospital in Medina, Ohio, part of The Cleveland Clinic Foundation. Ravkiran Khurana is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Ravkiran Khurana to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ravkiran Khurana practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ravkiran Khurana's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Ravkiran Khurana is board certified in internal medicine by the American Board of Internal Medicine. Ravkiran Khurana is licensed in Ohio.

CMS data shows 469 Medicare services from Ravkiran Khurana across 3 procedure codes in 2024, for 178 Medicare patients. Medicare paid $31,697 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 178 Medicare patients who saw Ravkiran Khurana in 2024. The largest group is 75 to 84, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ravkiran Khurana's median patient age at 71, with 57% women.

In 2024, Ravkiran Khurana wrote 274 Medicare Part D claims for 144 patients. 91% of them were for generic drugs. CMS names the drug for 96 of them, across 5 drugs with 11 or more claims each, at $11,937 in total drug cost. In 2023, CMS named 121 claims across 7 drugs.

Ravkiran Khurana accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Ravkiran Khurana from 2 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Calliditas Therapeutics US Inc. paid the most, $125.